Sodium oligomannate to prevent thinking problems after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether sodium oligomannate can help prevent or lessen memory and thinking problems that can happen after a first stroke. It may help people who are recently hospitalized for ischemic stroke and have mild cognitive decline risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had your first ischemic stroke (confirmed by CT or MRI)
- Your stroke happened within 7 days after you were admitted
- You are age 18 to 80 and your thinking is clear enough to do tests
- Before the stroke, your thinking and daily activities were normal
- Your screening memory/thinking test result is below the study cutoff (MoCA 22 or less after adjustment)
- You can give informed consent and stay living in the same place for over 3 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.
This study tests whether a therapy made from stem cell secretions can help improve memory and thinking after an ischemic stroke. It is for people who had a clot-related stroke in the past 3 months and now have mild to moderate cognitive issues.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
This trial tests whether a ginkgo biloba extract supplement can help improve thinking and memory after a stroke. It is for people who recently had a stroke and have some mild to moderate memory problems, but are not already taking other memory medications.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This study looks at whether using “osmotic” medicines during the first few days after a major stroke affects outcomes. It may help clarify which patients benefit and how to use these medicines safely.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.